Analyst Price Targets — RPID
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 22, 2026 12:38 pm | — | Lake Street | $7.00 | $2.09 | TheFly | Rapid Micro Biosystems price target lowered to $7 from $8 at Lake Street |
| May 11, 2022 9:38 am | — | Morgan Stanley | $8.00 | $4.11 | Benzinga | Morgan Stanley Maintains Equal-Weight on Rapid Micro Biosystems, Lowers Price Target to $8 |
Latest News for RPID
The heavy selling pressure might have exhausted for Rapid Micro Biosystems (RPID) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Many Bright Ideas Technologies (OTCMKTS:MBGNF - Get Free Report) and Rapid Micro Biosystems (NASDAQ: RPID - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Profitability This table compares Many
Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call Transcript
Rapid Micro Biosystems NASDAQ: RPID reported second-quarter revenue of $8.1 million, up 11% from $7.3 million a year earlier and above the company's prior guidance, as consumable sales, service activity and recurring revenue increased.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RPID.
U.S. House Trading
No House trades found for RPID.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.